摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-amino-6-propylpyrimidin-4(3H)-one

中文名称
——
中文别名
——
英文名称
2-amino-6-propylpyrimidin-4(3H)-one
英文别名
6-n-propyl-isocytosine;2-amino-6-propyl-1H-pyrimidin-4-one
2-amino-6-propylpyrimidin-4(3H)-one化学式
CAS
——
化学式
C7H11N3O
mdl
MFCD02091392
分子量
153.184
InChiKey
FSYKBAWAYYELHH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    67.5
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    [EN] CHEMICAL COMPOUNDS
    [FR] COMPOSÉS CHIMIQUES
    摘要:
    本发明涉及取代吲唑衍生物。具体而言,本发明涉及根据公式I的化合物:其中R1-R6和X在此定义。本发明的化合物是PDK1的抑制剂,可用于治疗由组成性激活的ACG激酶(如癌症,特别是白血病、乳腺癌、结肠癌和肺癌)引起的疾病。因此,本发明进一步涉及包含本发明化合物的药物组合物。本发明还进一步涉及使用本发明化合物或包含本发明化合物的药物组合物来抑制PDK1活性和治疗相关疾病的方法。
    公开号:
    WO2010120854A1
  • 作为产物:
    参考文献:
    名称:
    6-取代-2-氨基-5-溴-4(3H)-嘧啶酮的区域选择性合成及其抗病毒活性评价
    摘要:
    使用高度区域选择性的锂化-取代方案合成了一系列在 C-6 位置带有不同取代基的 2-amino-5-bromo-4(3 H )-嘧啶酮衍生物,以及 C-6 结构变化的影响评估了它们在细胞培养中的抗病毒活性的位置。尽管发现一些衍生物对各种病毒株具有活性,但它们仅在接近其毒性阈值时才有效。
    DOI:
    10.1016/j.ejmech.2013.06.036
点击查看最新优质反应信息

文献信息

  • Controlling Keto–Enol Tautomerism of Ureidopyrimidinone to Generate a Single-Quadruple AADD-DDAA Dimeric Array
    作者:Jing Zhang、Shuaiwei Qi、Chenyang Zhang、Zengming Fan、Qinwen Ding、Shizhong Mao、Zeyuan Dong
    DOI:10.1021/acs.orglett.0c02644
    日期:2020.9.18
    Units of ureidopyrimidinone (UPy) which dimerize via strong quadruple hydrogen bonding are widely used for the construction of supramolecular systems. This self-complementary system exists in the tautomerism equilibrium of 4[1H]-pyrimidinone dimer and pyrimidin-4-ol dimer, making generated supramolecular assembly systems essentially complicated. In this contribution, a rational but simple design concept
    通过强四重氢键二聚的脲基嘧啶酮(UPy)单元被广泛用于超分子体系的构建。这种自我互补的系统存在于4 [1 H ]-嘧啶酮二聚体和嘧啶丁-4-醇二聚体的互变异构平衡中,使生成的超分子组装系统实质上变得复杂。在此贡献中,描述了一种合理但简单的设计概念,用于通过超分子策略将UPy的自互补四氢键预组织为单四倍DDAA-AADD二聚体阵列。有了这个概念,设计的UPy导数仅形成4 [1 H从单晶X射线衍射和1 H NMR光谱中可以看出,在固态和溶液状态下,通过分子间氢键相互作用的具有酮构型的]-嘧啶酮二聚体。单个DDAA-AADD二聚体阵列提供了确定的非共价驱动力,可用于生成结构清晰的超分子结构,这在超分子化学和材料领域至关重要。
  • Direct synthesis of 5- and 6-substituted 2-aminopyrimidines as potential non-natural nucleobase analogues
    作者:K. Radhakrishnan、Namita Sharma、Lal Mohan Kundu
    DOI:10.1039/c4ra00249k
    日期:——
    A series of 2-aminopyrimidine derivatives, substituted at 5- and 6-positions, were synthesized. The reaction was carried out in a single step by treatment of the corresponding β-ketoester or β-aldehydoester with guanidine hydrochloride in the presence of K2CO3, in a microwave-assisted method without the requirement of solvent. A unique 1 : 1 co-crystal structure was obtained which shows that a 6-p
    合成了一系列5-和6-位取代的2-氨基嘧啶衍生物。该反应通过在K 2 CO 3存在下用盐酸胍处理相应的β-酮酸酯或β-醛二酸酯来一步进行。,不需要溶剂的微波辅助方法。获得独特的1:1共晶体结构,其显示6-苯基-2-氨基嘧啶酮与胞嘧啶形成强的核碱基对,涉及三个氢键。发现该碱基对与天然鸟嘌呤:胞嘧啶(G:C)一样强,表明合成衍生物的潜在应用。此外,我们还报告了第二个共晶体,该晶体以5:1的比例包含5-异丙基-6-甲基-2-氨基嘧啶酮和胞嘧啶,这也显示出很强的碱基配对特性。
  • Interferon induction
    申请人:The Upjohn Company
    公开号:US03932617A1
    公开(公告)日:1976-01-13
    A method and therapeutic compositions for inducing interferon formation in vivo. To a host is administered an interferon inducer of the formula: ##SPC1## Wherein X is a member selected from the group consisting of bromo and iodo and Y is a member selected from the group consisting of methyl and ethyl when X is bromo; or Y is a member selected from the group consisting of methyl, ethyl, n-propyl, benzyl and chloro when X is iodo.
    一种诱导体内干扰素形成的方法和治疗组合物。向宿主施用公式的干扰素诱导剂:## SPC1 ## 其中X是从溴和碘组成的组中选择的成员,当X是溴时,Y是从甲基和乙基组成的组中选择的成员;或者Y是从甲基、乙基、正丙基、苄基和氯组成的组中选择的成员,当X是碘时。
  • Phase change ink compositions
    申请人:Xerox Corporation
    公开号:US20030105185A1
    公开(公告)日:2003-06-05
    Disclosed is a phase change ink composition comprising a colorant and an ink vehicle, the ink being a solid at temperatures less than about 50° C. and exhibiting a viscosity of no more than about 20 centipoise at a jetting temperature of no more than about 160° C., wherein at a first temperature hydrogen bonds of sufficient strength exist between the ink vehicle molecules so that the ink vehicle forms hydrogen-bonded dimers, oligomers, or polymers, and wherein at a second temperature which is higher than the first temperature the hydrogen bonds between the ink vehicle molecules are sufficiently broken that fewer hydrogen-bonded dimers, oligomers, or polymers are present in the ink at the second temperature than are present in the ink at the first temperature, so that the viscosity of the ink at the second temperature is lower than the viscosity of the ink at the first temperature.
    本发明涉及一种相变墨水组合物,包括颜料和墨水载体,该墨水在低于约50℃的温度下为固体,并在不超过约160℃的喷射温度下表现出不超过约20厘泊的粘度。在第一温度下,墨水载体分子之间存在足够强度的氢键,以使墨水载体形成氢键二聚体、寡聚体或聚合物,而在第二温度下,该墨水载体分子之间的氢键被充分破坏,使得在第二温度下墨水中存在的氢键二聚体、寡聚体或聚合物比在第一温度下少,因此墨水在第二温度下的粘度低于在第一温度下的粘度。
  • PHASE CHANGE INK CONTAINING AMPHIPHILIC MOLECULE
    申请人:NORSTEN Tyler B.
    公开号:US20080100684A1
    公开(公告)日:2008-05-01
    Phase change ink comprising an ink vehicle that includes at least one amphiphilic molecule. The amphiphilic molecule is capable of co-crystallizing into the at least one wax monomer to form functionalized spherulites which are then capable of hydrogen bonding to other similarly functionalized spherulites to form a bonded network of spherulites. Increased adhesive and cohesive strength of the ink on paper can result, thereby generating a robust image.
    相变墨水包括至少一种含有两性分子的墨水载体。该两性分子能够与至少一种蜡单体共晶化,形成功能化的球晶体,然后能够与其他类似功能化的球晶体进行氢键作用,形成球晶体的粘结网络。这可能会增加墨水在纸张上的粘接和内聚力,从而产生强大的图像。
查看更多